对物质和酒精使用障碍的管理有前途的免疫调节剂
Amanda M Acuña1, Connor Park2, Jonna M Leyrer-Jackson2
1Department of Psychology, Behavioral Neuroscience and Comparative Psychology Area, Arizona State University, Tempe, Arizona, USA.
Expert opinion on pharmacotherapy
|May 28, 2024
概括
神经免疫系统为物质使用障碍 (SUD) 提供了新的希望. 免疫调节在减少胃口,炎症和改善SUD患者的认知功能方面表现有前途.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物使用障碍 (SUDs) 涉及复杂的神经免疫相互作用.
- 神经免疫系统是SUD的有希望的治疗目标.
- 免疫调节已经在SUDs的临床前和临床研究中证明了潜在的益处.
研究的目的:
- 审查对常见滥用物质的作用机制和免疫反应.
- 讨论针对神经精神疾病的免疫调节剂的非标签使用.
- 详细介绍特定免疫调节剂在治疗SUD方面的潜力.
主要方法:
- 对SUDs免疫调节的临床前和临床研究的审查.
- 对各种免疫调节剂的作用机制的分析.
- 对正在进行的SUD治疗临床试验的审查.
主要成果:
- 免疫调节剂在治疗与SUD相关的情感和行为障碍方面具有潜力.
- 针对SUD治疗,正在研究Ibudilast,Minocycline和Cannabidiol等特定药物.
- 这些药物可以减少物质使用,戒断严重程度,炎症,并改善认知功能.
结论:
- 混合的发现强调了免疫调节对SUDs的潜在益处.
- 免疫调节可以解决强迫性物质使用的行为,认知和炎症方面.
- 进一步的研究和临床试验对于验证这些发现至关重要.
关键词:
药物使用障碍物使用障碍物酒精使用障碍 饮酒障碍在Cannabidiol中使用.德克斯梅德米丁 (Dexmedetomidine) 是一种制剂.在Ibudilast上使用.米诺环素是什么意思?皮奥格利塔 (pioglitazone) 是一种药物.试验杀伤剂是一种杀伤剂.更多相关视频
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158
Substance Use Disorders Affecting Sleep
164
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
164
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Drugs Used in Lower Respiratory Disorders: Overview
421
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
421
CNS Depressants: Alcohol and Nicotine
203
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
203
Drugs for Treatment of Ulcerative Colitis in IBD
135
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
135


